These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 10338923)

  • 61. Can administration find cure for Medicare+Choice ills?
    Levin-Epstein M
    Manag Care; 1998 Dec; 7(12):12-3. PubMed ID: 10344803
    [No Abstract]   [Full Text] [Related]  

  • 62. 'Blueprint for the future' may lessen HMOs' impact. Interview by Frank Diamond.
    Berenson RA
    Manag Care; 2001 Jan; 10(1):20-5. PubMed ID: 11211325
    [No Abstract]   [Full Text] [Related]  

  • 63. Top developments in health care: a watershed year.
    Hagland MM
    Hospitals; 1991 Dec; 65(24):26-9. PubMed ID: 1660445
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perspectives. ACR showdown, mega-reg comments frame crucial payment, compliance, quality issues for Medicare+Choice.
    Cunningham R
    Med Health; 1998 Oct; 52(39):suppl 1-4. PubMed ID: 10339134
    [No Abstract]   [Full Text] [Related]  

  • 65. Conventional wisdom. A hopeful look forward.
    Rockefeller J
    Health Syst Rev; 1996; 29(4):42, 45. PubMed ID: 10162057
    [No Abstract]   [Full Text] [Related]  

  • 66. Washington: will Congress stop playing politics with health care?
    Pretzer M
    Med Econ; 1999 Jan; 76(1):83-4, 87-8, 91 passim. PubMed ID: 10351082
    [No Abstract]   [Full Text] [Related]  

  • 67. Medicare HMO pullouts: what do they portend for the future of Medicare+Choice?
    Jones NS
    Issue Brief Natl Health Policy Forum; 1999 Feb; (730):1-10. PubMed ID: 10558397
    [No Abstract]   [Full Text] [Related]  

  • 68. Medicinal marijuana?
    Grant D
    N Engl J Med; 1997 Apr; 336(16):1185; author reply 1186-7. PubMed ID: 9102570
    [No Abstract]   [Full Text] [Related]  

  • 69. Consumer advocacy in Medicare HMOs.
    Mallozzi J
    States Health; 1996 Dec; 6(8):1-10. PubMed ID: 11503875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Perspectives. Are unrealistic expectations confusing policy debate on Medicare HMOs?
    Cunningham R
    Med Health; 1999 Sep; 53(38):suppl 1-4. PubMed ID: 10621132
    [No Abstract]   [Full Text] [Related]  

  • 71. Medicare HMO marketing and information: keeping the focus on what consumers need.
    States Health; 1999 Apr; 9(1):1-10. PubMed ID: 11503889
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Family medicine: preparing for a high-performance health care system.
    Davis K; Stremikis K
    J Am Board Fam Med; 2010; 23 Suppl 1():S11-6. PubMed ID: 20207909
    [No Abstract]   [Full Text] [Related]  

  • 73. The new health agenda: an overview of the 100th Congress' health policy goals.
    Fintor L
    Group Pract J; 1987; 36(3):10-2, 14, 16. PubMed ID: 10301582
    [No Abstract]   [Full Text] [Related]  

  • 74. When you wish upon a Starr.
    Scully TA
    Hosp Outlook; 1998 Sep; 1(8):8. PubMed ID: 10186082
    [No Abstract]   [Full Text] [Related]  

  • 75. Health trends in the 1990s: tracking 10 years of "top 10 trends".
    Coile RC
    Russ Coiles Health Trends; 1999 Dec; 12(2):1-6. PubMed ID: 11185246
    [No Abstract]   [Full Text] [Related]  

  • 76. Medicare reform and the quality of health care.
    Simmons HE
    Cost Qual; 1999 Sep; 5(3):29-30. PubMed ID: 10622986
    [No Abstract]   [Full Text] [Related]  

  • 77. A conversation with ... C. Duane Dauner.
    Dauner CD
    Hosp Outlook; 1998 Oct; 1(9):10. PubMed ID: 10187191
    [No Abstract]   [Full Text] [Related]  

  • 78. The beginning of the end for HMOs. Part 1: The awakening market.
    Beckham JD
    Healthc Forum J; 1997; 40(6):44-7. PubMed ID: 10175123
    [No Abstract]   [Full Text] [Related]  

  • 79. Many happy returns. Insurers flock back to the Medicare managed-care market, but how long will they stick around this time?
    Benko LB
    Mod Healthc; 2006 Oct; 36(43):24-6, 28. PubMed ID: 17128586
    [No Abstract]   [Full Text] [Related]  

  • 80. Cost cost go away, is capitation here to stay?
    Altman SH
    Healthc Financ Manage; 1987 Mar; 41(3):22-35. PubMed ID: 10311916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.